CMP Price sensitive 10 Nov 2025, 8:59 AM

5th & New MEG Order

Compumedics Ltd

Compumedics secures 5th and new $4.9 million MEG order

Key points

  • New $4.9 million MEG sales order from Beijing Normal University, China
  • Total MEG orders now five, worth approximately $25 million in contracted revenues
  • Three systems to ship in FY26, with the newly secured system scheduled for FY27

Full summary

Compumedics Limited (ASX: CMP) has secured a new $4.9 million MEG sales order from the renowned Beijing Normal University in China. This takes the total MEG sales to five, representing about $25 million in contracted revenues for Compumedics' growing neuro-imaging business. The MEG system, along with a host of peripherals, will ship to Beijing Normal University in FY27, aligned with MEG production lead times. Beijing Normal University is one of China's top public universities, recognized globally for excellence in education and research. This new contract strengthens Compumedics' position in China's rapidly expanding neuro-imaging and brain-research market. The Company continues to achieve milestones in advancing the Orion LifeSpan™ MEG, including high-quality dual-helmet recordings, hyperscanning from both MEG sensor arrays, and powerful analysis capability via the newly released CURRY 9. Compumedics' MEG business continues to scale, providing a clear pathway to sustainable revenue growth. The $25 million MEG order book now underpins forward revenues through FY27, with additional opportunities being pursued across China, North America, and Europe.

Outlook

Compumedics' MEG business continues to scale, providing a clear pathway to sustainable revenue growth. The $25 million MEG order book now underpins forward revenues through FY27, with additional opportunities being pursued across China, North America, and Europe.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in